- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
RPG Life Sciences Limited — Board Meeting, 28-07-2026: Outcome of Board Meeting
28-07-2026 | 07:54 pm
28-07-2026 | 07:54 pm
RPG Life Sciences Board has approved its Q1 financial results. Consolidated Revenue from Operations was ₹195.69 Cr, with a Profit of ₹30.76 Cr for the quarter ended June 30, 2026. EPS stood at ₹18.60.
No comments yet. Be the first to comment!